These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28476816)

  • 1. Diagnostic Performance of a Novel Multiplex Immunoassay in Colorectal Cancer.
    Dressen K; Hermann N; Manekeller S; Walgenbach-Bruenagel G; Schildberg FA; Hettwer K; Uhlig S; Kalff JC; Hartmann G; Holdenrieder S
    Anticancer Res; 2017 May; 37(5):2477-2486. PubMed ID: 28476816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratin serum biomarkers in patients with colorectal cancer.
    Holdenrieder S; Stieber P; Liska V; Treska V; Topolcan O; Dreslerova J; Matejka VM; Finek J; Holubec L
    Anticancer Res; 2012 May; 32(5):1971-6. PubMed ID: 22593474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic relevance of a novel multiplex immunoassay panel in breast cancer.
    Hermann N; Dressen K; Schroeder L; Debald M; Schildberg FA; Walgenbach-Bruenagel G; Hettwer K; Uhlig S; Kuhn W; Hartmann G; Holdenrieder S
    Tumour Biol; 2017 Jun; 39(6):1010428317711381. PubMed ID: 28618926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
    Zhang SY; Lin M; Zhang HB
    Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
    Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
    Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of carcinoembryonic antigen (CEA), epidermal growth factor receptor (EGFR), epithelial cell adhesion molecule EpCAM (GA733-2), and carbohydrate antigen 19-9 (CA 19-9) levels in colorectal cancer patients and correlation with clinicopathological characteristics.
    Mourtzikou A; Stamouli M; Kroupis C; Christodoulou S; Skondra M; Kastania A; Pectasides D; Athanasas G; Dimas C
    Clin Lab; 2012; 58(5-6):441-8. PubMed ID: 22783573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary evaluation of clinical utility of CYFRA 21-1, CA 72-4, NSE, CA19-9 and CEA in stomach cancer.
    Gwak HK; Lee JH; Park SG
    Asian Pac J Cancer Prev; 2014; 15(12):4933-8. PubMed ID: 24998567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Serum Cytokeratines, Thymidine Kinase, and Growth Factors as Cancer Biomarkers in Colorectal Cancer.
    Karlíková M; Čurillová M; Pecen L; Karnos V; Karnos V; Topolčan O
    Anticancer Res; 2024 Jul; 44(7):3105-3113. PubMed ID: 38925804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of CYFRA 21-1 as a serum biomarker for the detection of colorectal adenoma and advanced colorectal adenoma in people over the age of 45.
    Lim DH; Lee JH; Kim JW
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28186354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3.
    Di Gioia D; Blankenburg I; Nagel D; Heinemann V; Stieber P
    Clin Chim Acta; 2016 Oct; 461():1-7. PubMed ID: 27451906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A system for tumor heterogeneity evaluation and diagnosis based on tumor markers measured routinely in the laboratory.
    Hui L; Rixv L; Xiuying Z
    Clin Biochem; 2015 Dec; 48(18):1241-5. PubMed ID: 26216289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study.
    Lumachi F; Lo Re G; Tozzoli R; D'Aurizio F; Facomer F; Chiara GB; Basso SM
    Anticancer Res; 2014 Nov; 34(11):6663-7. PubMed ID: 25368272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reference limits for chromogranin A, CYFRA 21-1, CA 125, CA 19-9 and carcinoembryonic antigen in patients with chronic kidney disease.
    Mikkelsen G; Åsberg A; Hultström ME; Aasarød K; Hov GG
    Int J Biol Markers; 2017 Oct; 32(4):e461-e466. PubMed ID: 28561881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
    Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
    Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples.
    Thomas DS; Fourkala EO; Apostolidou S; Gunu R; Ryan A; Jacobs I; Menon U; Alderton W; Gentry-Maharaj A; Timms JF
    Br J Cancer; 2015 Jul; 113(2):268-74. PubMed ID: 26035703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Performance of CEA, CA19-9, CA15-3, CA125 and AFP in Gastrointestinal Cancer Using LOCI™-based Assays.
    Dolscheid-Pommerich RC; Manekeller S; Walgenbach-Brünagel G; Kalff JC; Hartmann G; Wagner BS; Holdenrieder S
    Anticancer Res; 2017 Jan; 37(1):353-359. PubMed ID: 28011514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell factor (SCF) and interleukin 3 (IL-3) in the sera of patients with colorectal cancer.
    Mroczko B; Szmitkowski M; Wereszczyńska-Siemiatkowska U; Okulczyk B
    Dig Dis Sci; 2005 Jun; 50(6):1019-24. PubMed ID: 15986847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward standardized high-throughput serum diagnostics: multiplex-protein array identifies IL-8 and VEGF as serum markers for colon cancer.
    Bünger S; Haug U; Kelly FM; Klempt-Giessing K; Cartwright A; Posorski N; Dibbelt L; Fitzgerald SP; Bruch HP; Roblick UJ; von Eggeling F; Brenner H; Habermann JK;
    J Biomol Screen; 2011 Oct; 16(9):1018-26. PubMed ID: 21807963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.
    Feng M; Zhu J; Liang L; Zeng N; Wu Y; Wan C; Shen Y; Wen F
    Int J Clin Oncol; 2017 Apr; 22(2):283-290. PubMed ID: 27990560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.